BLRX
BioLineRx·NASDAQ
--
--(--)
--
--(--)
5.03 / 10
Netural
Sentiment is neutral (5.03/10) but fund‑flow scores 6.98/10, showing good inflows despite overall negative trends across size segments. Analyst consensus is bullish—three Strong Buy ratings—though historical win rates are mixed, yielding a cautiously optimistic view.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-17
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for BLRX?
- BLRX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.03/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
